Squarepoint’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $377K | Buy |
27,175
+8,842
| +48% | +$133K | ﹤0.01% | 3603 |
|
|
2026
Q2 | $308K | Buy |
+18,333
| New | +$257K | ﹤0.01% | 3787 |
|
|
2025
Q4 | – | Sell |
-16,265
| Closed | -$352K | – | 4824 |
|
|
2025
Q3 | $352K | Sell |
16,265
-36,801
| -69% | -$821K | ﹤0.01% | 3544 |
|
|
2025
Q2 | $1.18M | Sell |
53,066
-154,971
| -74% | -$3.44M | ﹤0.01% | 2520 |
|
|
2025
Q1 | $4.94M | Buy |
+208,037
| New | +$4.92M | 0.01% | 1429 |
|
|
2024
Q2 | – | Sell |
-39,406
| Closed | -$1.18M | – | 4587 |
|
|
2024
Q1 | $1.18M | Buy |
39,406
+20,785
| +112% | +$650K | ﹤0.01% | 2480 |
|
|
2023
Q4 | $596K | Sell |
18,621
-17,185
| -48% | -$499K | ﹤0.01% | 2878 |
|
|
2023
Q3 | $1.05M | Buy |
+35,806
| New | +$1.29M | ﹤0.01% | 2289 |
|
|
2022
Q4 | – | Sell |
-55,244
| Closed | -$1.29M | – | 3555 |
|
|
2022
Q3 | $1.29M | Buy |
55,244
+47,327
| +598% | +$1.51M | 0.01% | 1588 |
|
|
2022
Q2 | $229K | Buy |
+7,917
| New | +$346K | ﹤0.01% | 2402 |
|
|
2022
Q1 | – | Sell |
-9,491
| Closed | -$507K | – | 3445 |
|
|
2021
Q4 | $507K | Buy |
9,491
+4,548
| +92% | +$211K | ﹤0.01% | 2133 |
|
|
2021
Q3 | $209K | Buy |
4,943
+390
| +9% | +$19.9K | ﹤0.01% | 2467 |
|
|
2021
Q2 | $303K | Sell |
4,553
-20,257
| -82% | -$1.1M | ﹤0.01% | 2524 |
|
|
2021
Q1 | $1.1M | Buy |
+24,810
| New | +$921K | 0.01% | 1434 |
|
|
2020
Q4 | – | Sell |
-35,611
| Closed | -$780K | – | 3224 |
|
|
2020
Q3 | $780K | Buy |
35,611
+4,900
| +16% | +$87.1K | 0.01% | 1134 |
|
|
2020
Q2 | $355K | Buy |
+30,711
| New | +$337K | 0.01% | 1501 |
|
|
2020
Q1 | – | Sell |
-17,200
| Closed | -$269K | – | 2439 |
|
|
2019
Q4 | $269K | Sell |
17,200
-78,558
| -82% | -$891K | ﹤0.01% | 2094 |
|
|
2019
Q3 | $707K | Buy |
95,758
+46,891
| +96% | +$336K | 0.01% | 1434 |
|
|
2019
Q2 | $398K | Buy |
+48,867
| New | +$487K | ﹤0.01% | 1790 |
|
|
2019
Q1 | – | Sell |
-70,405
| Closed | -$689K | – | 2405 |
|
|
2018
Q4 | $689K | Buy |
70,405
+50,620
| +256% | +$679K | 0.01% | 1079 |
|
|
2018
Q3 | $326K | Buy |
+19,785
| New | +$316K | ﹤0.01% | 1494 |
|
|
2018
Q1 | – | Sell |
-22,681
| Closed | -$274K | – | 2098 |
|
|
2017
Q4 | $274K | Sell |
22,681
-8,783
| -28% | -$84K | ﹤0.01% | 1574 |
|
|
2017
Q3 | $326K | Buy |
+31,464
| New | +$450K | 0.01% | 1139 |
|
Other funds holding SGRY
Squarepoint's SGRY Position: Q3 2026 in Review
Squarepoint increased its Surgery Partners (SGRY) stake by 48% in Q3 2026, buying an estimated $133K and bringing the position to 27,175 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #3603.
Squarepoint first reported a position in SGRY in Q3 2017 and has held it in 23 quarters since. The position peaked at $4.94M in Q1 2025. 99 funds tracked by Wall St. Rank hold SGRY as of Q3 2026.
- Squarepoint held 27,175 shares of Surgery Partners worth $377K as of Q3 2026.
- Squarepoint bought 8,842 Surgery Partners shares in Q3 2026, an estimated $133K.
- Surgery Partners made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3603 holding.
- Squarepoint first reported a position in Surgery Partners in Q3 2017 and has held it in 23 quarters since.
- Squarepoint's Surgery Partners position peaked at $4.94M in Q1 2025.
- 99 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2026.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.